BACKGROUND AND AIMS: The exact nature of the epithelial barrier defect in Crohn's disease remains to be elucidated. Previously we showed increased permeability to proteins in ileal Crohn's disease. Our aims were to study if this barrier defect (a) involves endocytotic uptake of antigens and (b) is related to low grade inflammation not detectable by histology. METHODS: Macroscopically normal segments of distal ileum of Crohn's disease patients (n = 10) were subgrouped into non-inflamed (histologically unaffected) and slightly inflamed tissues and studied in Ussing chambers, with normal ileal specimens from colon cancer patients (n = 9) as controls. Endocytotic uptake into enterocytes of the protein antigen horseradish peroxidase was assessed by measuring the area of horseradish peroxidase containing endosomes in electron photomicrographs. Mucosal tumour necrosis factor alpha (TNF-alpha) mRNA was quantified using real time polymerase chain reaction. For comparison, the effects of low doses of TNF-alpha on endosomal uptake of horseradish peroxidase were studied in cultured T84 cells grown on filter supports. RESULTS: The area of horseradish peroxidase containing endosomes was increased (p<0.001) in enterocytes of non-inflamed ileum of Crohn's disease (2.8 (0.7) mum(2)/300 mum(2)) compared with control ileum (0.6 (0.06)). In non-inflamed mucosa, a significant association between endosomal uptake and mucosal expression of TNF-alpha mRNA (p = 0.03) was found. Low concentrations of TNF-alpha (0.25-1.0 ng/ml) enhanced the endosomal uptake of horseradish peroxidase in polarised T84 cells, without affecting transepithelial electrical resistance. CONCLUSIONS: Our findings suggest increased endosomal uptake of antigens in ileal Crohn's disease that may be mediated by TNF-alpha. These data highlight the transcellular route of antigen uptake in barrier dysfunction and implicate the interaction between epithelial cells and the innate immune system in the development of mucosal inflammation.
BACKGROUND AND AIMS: The exact nature of the epithelial barrier defect in Crohn's disease remains to be elucidated. Previously we showed increased permeability to proteins in ileal Crohn's disease. Our aims were to study if this barrier defect (a) involves endocytotic uptake of antigens and (b) is related to low grade inflammation not detectable by histology. METHODS: Macroscopically normal segments of distal ileum of Crohn's diseasepatients (n = 10) were subgrouped into non-inflamed (histologically unaffected) and slightly inflamed tissues and studied in Ussing chambers, with normal ileal specimens from colon cancerpatients (n = 9) as controls. Endocytotic uptake into enterocytes of the protein antigen horseradish peroxidase was assessed by measuring the area of horseradish peroxidase containing endosomes in electron photomicrographs. Mucosal tumour necrosis factor alpha (TNF-alpha) mRNA was quantified using real time polymerase chain reaction. For comparison, the effects of low doses of TNF-alpha on endosomal uptake of horseradish peroxidase were studied in cultured T84 cells grown on filter supports. RESULTS: The area of horseradish peroxidase containing endosomes was increased (p<0.001) in enterocytes of non-inflamed ileum of Crohn's disease (2.8 (0.7) mum(2)/300 mum(2)) compared with control ileum (0.6 (0.06)). In non-inflamed mucosa, a significant association between endosomal uptake and mucosal expression of TNF-alpha mRNA (p = 0.03) was found. Low concentrations of TNF-alpha (0.25-1.0 ng/ml) enhanced the endosomal uptake of horseradish peroxidase in polarised T84 cells, without affecting transepithelial electrical resistance. CONCLUSIONS: Our findings suggest increased endosomal uptake of antigens in ileal Crohn's disease that may be mediated by TNF-alpha. These data highlight the transcellular route of antigen uptake in barrier dysfunction and implicate the interaction between epithelial cells and the innate immune system in the development of mucosal inflammation.
Authors: Mark W Musch; Lane L Clarke; Daniel Mamah; Lara R Gawenis; Zheng Zhang; William Ellsworth; David Shalowitz; Navdha Mittal; Petros Efthimiou; Ziad Alnadjim; Steve D Hurst; Eugene B Chang; Terrence A Barrett Journal: J Clin Invest Date: 2002-12 Impact factor: 14.808
Authors: Heinz Schmitz; Katharina Rokos; Peter Florian; Alfred H Gitter; Michael Fromm; Peter Scholz; Reiner Ullrich; Martin Zeitz; Georg Pauli; Jörg-Dieter Schulzke Journal: AIDS Date: 2002-05-03 Impact factor: 4.177
Authors: J D Söderholm; G Olaison; K H Peterson; L E Franzén; T Lindmark; M Wirén; C Tagesson; R Sjödahl Journal: Gut Date: 2002-03 Impact factor: 23.059
Authors: Johan D Söderholm; Ping-Chang Yang; Peter Ceponis; Angeli Vohra; Robert Riddell; Philip M Sherman; Mary H Perdue Journal: Gastroenterology Date: 2002-10 Impact factor: 22.682
Authors: James Yoo; Anthony Nichols; Jaekyung C Song; Joshua Mammen; Isabel Calvo; Roger T Worrell; John Cuppoletti; Karl Matlin; Jeffrey B Matthews Journal: Am J Physiol Gastrointest Liver Physiol Date: 2002-12-27 Impact factor: 4.052
Authors: Peter Suenaert; Veerle Bulteel; Liesbeth Lemmens; Maja Noman; Benny Geypens; Gert Van Assche; Karel Geboes; Jan L Ceuppens; Paul Rutgeerts Journal: Am J Gastroenterol Date: 2002-08 Impact factor: 10.864
Authors: Bjarni Thjodleifsson; Gudmundur Sigthorsson; Nick Cariglia; Inga Reynisdottir; Daniel F Gudbjartsson; Kristleifur Kristjansson; Jonathan B Meddings; Vilmundur Gudnason; Johan H Wandall; Leif Percival Andersen; Roy Sherwood; Matthias Kjeld; Einar Oddsson; Hallgrimur Gudjonsson; Ingvar Bjarnason Journal: Gastroenterology Date: 2003-06 Impact factor: 22.682
Authors: Stephan R Vavricka; Mark W Musch; Mikihiro Fujiya; Keri Kles; Laura Chang; Jyrki J Eloranta; Gerd A Kullak-Ublick; Ken Drabik; Didier Merlin; Eugene B Chang Journal: Pflugers Arch Date: 2005-11-19 Impact factor: 3.657
Authors: Antonio M Scanu; Tim J Bull; Sara Cannas; Jeremy D Sanderson; Leonardo A Sechi; Giuseppe Dettori; Stefania Zanetti; John Hermon-Taylor Journal: J Clin Microbiol Date: 2007-10-03 Impact factor: 5.948